Bovine herpesvirus-1 (BHV-1) recombinant expressing pseudorabies virus (PrV) glycoproteins B and C induces type 1 immune response in BALB/c mice

Journal of Veterinary Medical Science

Volumn 64, Issue 7, 2002, Pages 589-596

  Takashima, Yasuhiro ^a   Nagane, Noriko ^a   Hushur, Orkash ^a   Matsumoto, Yasunobu ^a   Otsuka, Haruki ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

BHV 1; IgG1 igG2a; PrV

Indexed keywords

BOVINE HERPESVIRUS 1; HUMAN HERPESVIRUS 1; SUID HERPESVIRUS 1;

IMMUNOGLOBULIN G; PSEUDORABIES VIRUS GLYCOPROTEINS; RECOMBINANT DNA; VIRUS ANTIBODY; VIRUS ENVELOPE PROTEIN;

ANIMAL; ANTIBODY SPECIFICITY; ARTICLE; BAGG ALBINO MOUSE; DELAYED HYPERSENSITIVITY; GENETIC ENGINEERING; GENETICS; IMMUNIZATION; IMMUNOLOGY; INFECTIOUS BOVINE RHINOTRACHEITIS VIRUS; MOUSE; PHYSIOLOGY; PSEUDORABIES HERPETOVIRUS; TH1 CELL; TIME;

ANIMALS; ANTIBODIES, VIRAL; DNA, RECOMBINANT; GENETIC ENGINEERING; HERPESVIRUS 1, BOVINE; HERPESVIRUS 1, SUID; HYPERSENSITIVITY, DELAYED; IMMUNIZATION; IMMUNOGLOBULIN G; MICE; MICE, INBRED BALB C; ORGAN SPECIFICITY; TH1 CELLS; TIME FACTORS; VIRAL ENVELOPE PROTEINS;

EID: 0036631890     PISSN: 09167250     EISSN: None     Source Type: Journal    
DOI: 10.1292/jvms.64.589     Document Type: Article

References (30)

1. Baskerville, A., Macferran, J. B. and Dow, C. 1973. Aujeszky's disease in pigs. Vet. Bull. 43: 465-480.
2. Chappnis, G., Fargeaud, D. and Brun, A. 1989. Industrial production and control of a subunit vaccine against Aujeszky's disease. pp. 67-78. In: Vaccination and Control of Aujeszky's Disease (Van Oirschot, J. T. ed.), Kluwer Academic Publishers, Dordrecht.
3. Derbyshire, J. B. and Caplan, B. A. 1976. The isolation and characterization of a strain of infectious bovine rhinotracheitis virus from stillbirth in swine. Can. J. Comp. Med. 40: 252-256.
4. Gibbs, E. P. J. and Rweyemamu, M. M. 1977. Bovine herpesvirus. 1. Vet. Bull. 47: 317-343.
5. Iglesias, G. J. and Harkness, J. W. 1988. Studies of transplacental and perinatal infection with two clones of a single Aujeszky's disease (pseudorabies) virus isolate. Vet. Microbiol. 16: 243-254.
6. Iglesias, G. J. Trujano, M., Lokensgard, J. and Molitor, T. 1992. Study of the potential involvement of pseudorabies virus in swine respiratory disease. Can. J. Vet. Res. 56: 74-77.
7. Ikeda, Y., Shibata, I., Xuan, X., Matsumoto, Y. and Otsuka, H. 2000. Immunogenic properties of a bovine herpesvirus-1 (BHV-1) recombinant expressing major pseudorabies virus (PrV) glycoproteins in combination. J. Vet. Med. Sci. 62: 849-859.
8. Ishii, H., Kobayashi, Y., Kuroki, M. and Kodama, Y. 1988. Protection of mice from lethal infection with Aujeszky's disease virus by immunization with purified gVI. J. Gen. Virol. 69: 1411-1414.
9. Keil, G. M., Engelhardt, T., Karger, A. and Enz, M. 1996. Bovine Herpesvirus U(s) open reading frame 4 encodes a glycoproteoglycan. J. Virol. 70: 3032-3038.
10. Kimman, T. G. 1993. Characterization of the pseudorabies virus-specific immunoglobulin M response and evaluation of its diagnostic use in pigs with preexisting immunity to the virus. J. Clin. Microbiol. 31: 2309-2314.
11. Lupton, H. W., Barns, H. J. and Reed, D. E. 1980. Evaluation of the rabbit as laboratory model of infectious bovine rhinotracheitis virus infection. Cornell Vet. 70: 77-95.
12. Maes, R.K. and Schutz, J.C. 1983. Evaluation in swine at a subunit vaccine against pseudorabies. Am. J. Vet. Res. 44: 123-125.
13. Marchioli, C. C., Yancey, R. J. Jr., Wardley, R. C., Tormasen, D. R. and Post, L. E. 1987. A vaccine strain of pseudorabies virus with deletions in the thymidine kinase and glycoprotein X genes. Am. J. Vet. Res. 48: 1577-1583.
14. Matsuda-Tsuchida, A., Katayama, S., Okada, N., Okabe, T. and Sasaki, N. 1992. Protection from pseudorabies virus challenge in mice by a recombination of purified gII, gIII and gVI antigen. J. Vet. Med. Sci. 54: 447-452.
15. McFarland, M. D. and Hill, H. T. 1987. Vaccination of mice and swine with a pseudorabies mutant lacking thymidine kinase activity. Can. J. Vet. Virol. 51: 340-344.
16. Mengeling, W.L. 1989. Latent infection and subsequent reactivation of pseudorabies virus in swine exposed to pseudorabies virus while nursing immune dams. Am. J. Vet Res. 50: 1658-1966.
17. Mohanty, S. B., Lillie, M. G., Corcelius, N. P. and Beck, J. D. 1972. Natural infection with infectious bovine rhinotracheitis virus in goats. J. Am. Vet. Med. Assoc. 160: 879-880.
18. Nakamichi, K. and Otsuka, H. 2000. Attachment and penetration properties of bovine herpesvirus 1 recombinants expressing pseudorabies virus glycoproteins gC and gB. Intervirology 43: 87-94.
19. Nakamichi, K., Matsumoto, Y. and Otsuka, H. 2001. Defective infection of bovine herpesvirus 1 in mon-permissive murine cells. J. Vet. Med. Sci. 63: 1139-1142.
20. Nelson, D. R., Mare, C. J. and Glock, R. D. 1972. Infectious bovine rhinotracheitis (herpes bovis) infection in swine. Am. J. Vet. Res. 33: 1209-1215.
21. Otsuka, H. and Xuan, X. 1996 Construction of bovine herpesvirus-1 (BHV-1) recombinants which express pseudorabies virus (PrV) glycoprotein gB, gC, gD and gE. Arch. Virol. 141: 57-71.
22. Otsuka, H., Xuan, X., Shibata, I. and Mori, M. 1996. Protective immunity of bovine herpesvirus-1 (BHV-1) recombinants which express pseudorabies virus (PRV) glycoprotein gB, gC, gD and gE. J. Vet. Med. Sci. 58: 819-824.
23. Pensaert, M. B., De Smet, K. and Waele, K. 1990. Extent and duration of virulent virus excretion upon challenge of pigs vaccinated with different glycoprotein-deleted Aujeszky's disease vaccines. Vet. Microbiol. 22: 107-117.
24. Platt, K. B. 1984. The evaluation of a lectin-agarose based subunit vaccine and complementary diagnostic antigen for Aujeszky's disease (pseudorabies) in the pig. Vet. Microbiol. 9: 35-51.
25. Porter, D. D., Larsen, A. E. and Cox, N. A. 1975. Isolation of infectious bovine rhinotracheitis virus from Mustelidae (minks). J Clin. Microbiol. 1: 112-113.
26. Riviere, M., Tartaglia, J., Perkus, M. E., Norton, E. K., Bongermino, C. M., Lacoste, F., Duret, C., Desmettre, P. and Paoletti, E. 1992. Protection of mice and swine from pseudorabies virus conferred by vaccinia virus-based recombinants. J. Virol. 66: 3424-3434.
27. Takashima, Y., Xuan, X., Nagasawa, H., Matsumoto, Y., Igarashi, I., Fujisaki, K., Mikami, T. and Otsuka, H. 2001. Construction of the recombinant pseudorabies viruses expressing Cryptosporidium parvum an immunodominant surface protein, p23. J. Protozool. Res. (in press).
28. Takashima Y., Xuan, X., Nagane, N., Nagasawa, H., Matsumoto, Y., Inoue, N., Igarashi, I., Fujisaki, K., Mikami, T. and Otsuka, H. 2002. Construction of recombinant bovine herpesvirus-1 (BHV-1) expressing an immunodominant surface protein, p23 of Cryptosporidium parvum as a vaccine for cryptosporidiosis (submitting).
29. Vannier, P., Hutet, E., Bourgueil, E. and Cariolet, R. 1991. Level of virulent virus excreted by infected pigs previously vaccinated with different glycoprotein deleted Aujeszky's disease vaccines. Vet. Microbiol. 29: 213-223.
30. Yamada, S. and Shimizu, M. 1993. Isolation and characterization of pseudorabies virus with deletion in the immediate-early regulatory gene. Virology 199: 366-375.